日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Chinadaily.com.cn
 
Go Adv Search

China's mums key to Nestle baby milk deal

Updated: 2012-04-25 11:19

(Agencies)

  Comments() Print Mail Large Medium  Small

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

主站蜘蛛池模板: 男女黄色一级片 | 九九在线精品视频 | 手机看片在线观看 | 性欧美极品另类 | 青青国产在线视频 | 清纯唯美激情 | 亚洲欧美小视频 | 国产麻豆一区二区 | 精品在线视频免费观看 | 欧美xx孕妇 | 在线观看欧美精品 | 天天婷婷 | 日韩有码第一页 | 黄色在线观看国产 | 狠狠干中文字幕 | √天堂中文官网8在线 | 最新日韩中文字幕 | 日韩一区欧美一区 | 日韩午夜在线 | 日韩在线h| 精品无人国产偷自产在线 | 手机在线小视频 | 亚洲自拍偷拍视频 | 成人欧美视频 | 欧美三区在线观看 | 日本一级在线观看 | 超碰精品在线观看 | 久久久穴 | 亚洲自拍偷拍网站 | 久久久日本 | 精品久久久一区二区 | 99精品久久久 | 亚洲免费黄色片 | 99久久久久 | 天堂а√在线中文在线鲁大师 | 福利精品视频 | 91精品久久久久久综合五月天 | 911香蕉 | 欧美久久一区二区三区 | 日本全裸美女 | 激情丁香网 |